Technical Articles

Statin Drugs
基于TR-FRET技术的PCSK9靶向血脂调节药物研究进展
Research Progress on PCSK9-Targeted Lipid-Regulating Drugs Based on TR-FRET Technology
发布时间 2026-04-13
PCSK9 is a serine protease synthesized by the liver and responsible for regulating protein activity, first reported in 2003. In 2004, studies found that overexpression of PCSK9 in rodent experiments led to a reduction in LDL-R and an increase in LDL-C.
View details
  • Drug Research
  • TR-FRET Technology
  • PCSK9 (D347Y)/LDLR
  • Statin Drugs
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.